{"id":449849,"date":"2025-12-31T00:30:00","date_gmt":"2025-12-30T23:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/aumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares\/"},"modified":"2025-12-30T23:25:18","modified_gmt":"2025-12-30T22:25:18","slug":"aumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/aumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares\/","title":{"rendered":"Aumentan las opciones de tratamiento farmacol\u00f3gico: pruebas espectaculares"},"content":{"rendered":"\n<p><strong>En las \u00faltimas d\u00e9cadas, la incidencia de la enfermedad hep\u00e1tica esteat\u00f3sica ha aumentado de forma paralela al incremento de la obesidad, la diabetes y otras enfermedades metab\u00f3licas. Se recomienda examinar de forma selectiva a los pacientes de riesgo. En los \u00faltimos tiempos se han logrado avances significativos. Estudios recientes han identificado subtipos de MASLD con diferentes perfiles de riesgo cardiovascular. La aprobaci\u00f3n por la FDA y la EMA del resmetirome representa un avance importante en el campo de la terapia farmacol\u00f3gica para el MASLD. Sin embargo, la situaci\u00f3n de los datos de la semaglutida administrada por v\u00eda subcut\u00e1nea tambi\u00e9n es prometedora, como muestran los an\u00e1lisis provisionales actuales.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Faumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>En las \u00faltimas d\u00e9cadas, la incidencia de la enfermedad hep\u00e1tica esteat\u00f3sica ha aumentado de forma paralela al incremento de la obesidad, la diabetes y otras enfermedades metab\u00f3licas. Se recomienda examinar&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Faumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":449850,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"MASLD\/MASH  ","footnotes":""},"category":[11483,11475,11358,11288,11552],"tags":[24812,83707,77521,45583,87002,77523,17397],"powerkit_post_featured":[],"class_list":["post-449849","post","type-post","status-publish","format-standard","has-post-thumbnail","category-el-congreso-informa","category-estudios","category-gastroenterologia-y-hepatologia","category-medicina-interna-general","category-rx-es","tag-enfermedad-hepatica","tag-mash-es-2","tag-masld-es","tag-nash-es","tag-opciones-de-tratamiento-farmacologico","tag-resmetirom-es","tag-semaglutida-es","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-11 06:08:49","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=449849"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449849\/revisions"}],"predecessor-version":[{"id":460301,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449849\/revisions\/460301"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/449850"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=449849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=449849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=449849"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=449849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}